Effect of 3′-azido-3′-deoxythymidine on replication of duck hepatitis B virus in vivo and in vitro
- 9 December 1989
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 29 (4) , 244-248
- https://doi.org/10.1002/jmv.1890290405
Abstract
3′‐Azido‐3′‐deoxythymidine (AZT) inhibits the replication of the human immunodeficiency virus (HIV) by blocking the formation of the phosphodiester bond and has been used clinically for the treatment of HIV infection. To assess the effect of AZT on the replication of hepadnaviruses, which replicate through reverse transcription, both the liver tissue and primary cultured hepatocytes from ducklings previously infected with duck hepatitis B virus (DHBV) were examined for DHBV DNA before and after the treatment with AZT. We did not observe suppression of DHBV replication at any doses in our system as measured by viral DNA synthesis in infected duck hepatocytes. The data strongly suggest that AZT has no inhibitory effect on DHBV reverse transcriptase.Keywords
This publication has 9 references indexed in Scilit:
- In Vitro transmission of duck hepatitis B virus to primary duck hepatocyte culturesHepatology, 1988
- Inhibition of hepatitis B virus DNA polymerase by 3′‐azido‐3′‐deoxythymidine triphosphate but not by its threo analogJournal of Medical Virology, 1987
- Controlled clinical trial of acyclovir in chronic hepatitis B virus infectionJournal of Medical Virology, 1987
- Occurrence and ultrastructural localization of duck hepatitis B virus in the liver of ducks after experimental infectionHepatology, 1987
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences, 1985
- Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediatePublished by Elsevier ,1982
- Long-term follow-up of chronic active hepatitis of moderate severity.Gut, 1978
- Hepatitis-Associated Antigen and Hepatocellular Carcinoma in TaiwanAnnals of Internal Medicine, 1971